Genetic Susceptibility to Coronavirus Disease 19 (COVID-19): A Review
Keywords:
COVID-19, Gene, Immune system, Susceptibility, X-chromosome.Abstract
Background: Certain gene polymorphisms are suspected to contribute to the geographic-specific susceptibility of people to coronavirus disease 19 (COVID-19), which may be used as therapeutic targets. Accordingly, this review articulates suspected COVID-19 susceptibility genes to assist researchers and medical practitioners to formulate effective drug and treatment procedure.
Method: Reputable electronic academic databases, including PubMed, Springer Link, and Scopus were searched for relevant information on the subject.
Results and Discussion: The search identified seven COVID-19 susceptibility genes, which are TICAM2, TLRs, ACE, ABO blood group gene, HLA, and TMPRSS2. Polymorphisms in ACE and TMPRSS2 may increase or decrease the binding of the virus to the human cell, while polymorphisms in TICAM2, TLRs, and HLA may enhance or compromise the immune system. Type O blood group seems to be the most protective ABO blood group because of its abundant antibodies and blood clothing inhibition, while type A blood group is the least protective. The distribution of the polymorphisms is influenced by geographical locations, which could contribute to the worldwide differential vulnerability of people to the disease. Most protective polymorphisms are prevalent among Africans and Asians, which could be the reason for their less susceptible to the disease compared to Europeans and Americans. Most genes reside on the X - chromosome, which could partly explain the dominance of the severe form of the disease among men than women.
Conclusion: Polymorphisms in certain genes may modulate COVID-19 infectivity and severity. A thorough understanding of the biological mechanisms of these genes may help design a cure.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Tajudeen Yahaya, Esther Oladele, Kelechi Nnochiri, Haliru Abdullahi, Josephine Nathaniel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
